Diana Shipping Inc. Announces Direct Continuation of Time Charter Contract for m/v Melia With Nidera
Mar 16, 2017 12:45 pm UTC| Business
ATHENS, Greece, March 16, 2017 -- Diana Shipping Inc. (NYSE:DSX) (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned...
IES Holdings Acquires Freeman Enclosure Systems, LLC
Mar 16, 2017 12:41 pm UTC| Business
HOUSTON, March 16, 2017 -- IES Holdings, Inc. (or “IES”) (NASDAQ:IESC) today announced that its subsidiary IES Infrastructure Solutions, LLC has acquired all of the membership interests of Freeman Enclosure Systems, LLC...
Middlesex University Adopts Avid NEXIS For Cutting-Edge Education Infrastructure
Mar 16, 2017 12:30 pm UTC| Business
BURLINGTON, Mass., March 16, 2017 -- Avid® (Nasdaq:AVID) today announced that the Faculty of Arts and Creative Industries at Middlesex University, an internationally recognized higher education institution in London,...
Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2016
Mar 16, 2017 12:30 pm UTC| Business
MIGDAL HAEMEQ, Israel, March 16, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based nutritional ingredients and medical...
CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City
Mar 16, 2017 12:30 pm UTC| Business
OXNARD, Calif., March 16, 2017 -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “company”), a leading disruptive drug delivery technology company serving the pharmaceutical, biotech, veterinarian, nutraceutical and...
Mar 16, 2017 12:30 pm UTC| Business
CHICAGO, March 16, 2017 -- VelocityEHS,the leading cloud environment, health, safety (EHS) and sustainability software provider, today announced it is expanding its MSDSonline Regulatory Consulting Services to help EHS...
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial Results
Mar 16, 2017 12:30 pm UTC| Business
NEWTOWN, Pa., March 16, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer,...